|
|
Post by orlon on Feb 21, 2017 16:48:34 GMT -5
It seems to me that keeping the PPS at close to .50c will mean a 1:10 reverse split come March. But I am not very hopefull that short sellers will not attempt to bring the PPS back down to around $1.00. Major pharmas have one reason to destroy the company...profit, and the best way is to do that is short it out of existence. No fingerprints.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Feb 21, 2017 16:53:07 GMT -5
It seems to me that keeping the PPS at close to .50c will mean a 1:10 reverse split come March. But I am not very hopefull that short sellers will not attempt to bring the PPS back down to around $1.00. Major pharmas have one reason to destroy the company...profit, and the best way is to do that is short it out of existence. No fingerprints. Can you put down what ever you have been smoking? Are they telling MNKD not to advertise? Nor raise funds when they could? And are they telling patients not to ask your doc about Afrezza? |
|
|
|
Post by babaoriley on Feb 21, 2017 16:57:09 GMT -5
But, iam2, I do think reps from competitors are cautioning their customer docs from going with what they can argue somewhat persuasively, is a failing company.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Feb 21, 2017 17:01:45 GMT -5
But, iam2, I do think reps from competitors are cautioning their customer docs from going with what they can argue somewhat persuasively, is a failing company. That's just the nature of the business then. Insane that most reps can't even get docs time but these reps can get docs time plus talk about competing insulin too. Ok |
|
|
|
Post by babaoriley on Feb 21, 2017 17:48:00 GMT -5
iam2, we're talking about reps who actually have fostered decent relationships with docs over the years. Lots of ways that can be done, but it takes a long time.
|
|
